A5018111914- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Cardiac Arrest and Resuscitation
- Congenital Heart Disease Studies
- Cardiac pacing and defibrillation studies
- Cardiac Valve Diseases and Treatments
- Fuel Cells and Related Materials
- Heart Failure Treatment and Management
- Engineering Technology and Methodologies
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Cardiac and Coronary Surgery Techniques
- Transplantation: Methods and Outcomes
- Heparin-Induced Thrombocytopenia and Thrombosis
- Engineering Diagnostics and Reliability
- Medical and Biological Sciences
- Cerebrospinal fluid and hydrocephalus
- Cardiac Ischemia and Reperfusion
- Trauma Management and Diagnosis
- Diverse Industrial Engineering Technologies
- Advanced Theoretical and Applied Studies in Material Sciences and Geometry
- Neurological Disorders and Treatments
- Aortic Disease and Treatment Approaches
- Advanced machining processes and optimization
- Medical research and treatments
Hospital Clínico Universitario de Valladolid
2020-2025
Kirov State Medical Academy
2024
S. M. Kirov Military Medical Academy
2024
Centro de Investigación en Red en Enfermedades Cardiovasculares
2020-2023
Centro de Investigación Biomédica en Red
2021-2023
Universidad de Valladolid
2020-2021
Deutsches Herzzentrum der Charité
2008-2017
Berlin Heart (Germany)
2009-2016
I.Horbachevsky Ternopil National Medical University
2015
Ukrainian Military Medical Academy
2015
Up to 30% of patients with end-stage heart failure experience biventricular that requires mechanical support. For these patients, only bulky extracorporeal or implantable displacement pumps the total artificial have been available date, which enables limited quality life for patients. It was our goal evaluate a method would allow use 2 centrifugal left ventricular assist devices as system.Seventeen implanted HeartWare HVAD pumps, 1 device and right device. Seventy-seven percent had...
Unloading-promoted reversal of heart failure (HF) allows long-term transplant-free outcome after ventricular assist device (VAD) removal. However, because few patients with chronic cardiomyopathy (CCM) were weaned from VADs (the majority only recently), the reliability criteria used for weaning decisions to predict post-weaning success is barely known. After 15 years experience, we assessed this issue.In 47 CCM as underlying cause HF, who part a total 90 bridge-to-transplant-designed since...
Background— Left ventricular assist devices (LVADs) provide better outcome than biventricular devices, but it is a challenge to predict the impact of LV mechanical unloading on postoperative right (RV) function preoperatively. We assessed load dependency in RV performance before and after LVAD implantation aiming improve preoperative decision making. Methods Results— Laboratory, echocardiography, heart catheterization data collected from 205 patients were tested for relationship with...
Abstract Early planned institution of temporary right ventricular assist device ( RVAD ) support with the C entri M ag L evitronix LLC , W altham, MA USA in left LVAD recipients was compared permanent biventricular BVAD or total artificial heart TAH support. Between 2007 and 2011, 77 patients (age range: 25–70 years) preoperative evidence dysfunction U niversity P ennsylvania score >50; ichigan >5) were included. Forty‐six (38 men; median age 54.5 years, underwent placement combined...
Transcatheter aortic valve replacement (TAVR) in non-calcified regurgitation (NCAR) is an off-label procedure. The balloon-expandable Myval includes extra-large sizes (30.5 mm and 32 mm) of interest this setting.
Aortic valve regurgitation or the presence of a mechanical aortic prosthesis is relative contraindication for implantation left ventricular assist devices (LVAD). However, concomitant replacement by biological one options in this situation. We analyzed our recent experience with device and replacement.Between January 1, 2008 15, 2012, 318 adult patients (>18 years old) were supported long-term implantable LVAD institution. In 19, simultaneous (6 redo 13 primary procedures) was performed....
Implantation of rotary blood pumps is an established treatment for end-stage heart failure. Anticoagulation routinely used reducing pump thrombosis, but this severe complication still occurs in 5-8% patients. In 105 patients, the sound produced by left ventricular assist device HeartWare HVAD was prospectively and sequentially recorded. The acoustic spectra calculated runtime fast Fourier transformation were investigated. Results compared with respect to patients without thrombotic...
Abstract Introduction Veno-arterial extracorporeal membrane oxygenation support (VA-ECMO) is an effective therapy in refractory cardiogenic shock and cardiorespiratory arrest. Sex-related differences regarding presentation outcomes are not well stablished this scenario. Methods Descriptive, retrospective single-center study that includes all patients who required VA-ECMO between 2021 2023. The main objective was to compare clinical characteristics, evolution mortality both sexes. Results 78...
Abstract Introduction Coronary artery disease (CAD) is one of the primary causes dilated cardiomyopathy in our population. However, both need for revascularization and type coronary these patients a matter od debate afther de publication latest clinical trial. Objective The aim to describe characteristics this patient population, selected, outcomes observed real-world cohort. Methods A retrospective study was conducted on consecutive presenting with onset ischemic between 2019 2023 at...
Abstract Introduction Cardiac arrest prognosis remains grim even when resuscitation manouvers are started immediately. Extracorporeal cardiopulmonary (ECPR) in refractory cardiac has proved to reduce mortality this scenario, though there is still insufficient evidence make a widespread recommendation of approach. Complications related cannulation ECPR likely and they can negatively impact survival context. The goal research analyze results patients our hospital compare them with the rest...
Abstract Background Advanced heart failure patients are often admitted to intensive care unit (ICU) due cardiogenic shock and needing mechanical support as a bridge urgent cardiac transplant (CTx). The latest device used for this purpose has been percutaneous ventricular assistance with full (Impella 5.0 5.5), first approved in the US 2019. It emerged possibly effective less invasive alternative surgical devices, but experience is still very limited some centres patient profiles. Purpose of...
We have developed a method that allows the use of commercially available implantable left ventricular assist device (LVAD; HeartWare HVAD) for right (RV) assistance. A mock circulation was used to examine flow characteristics system with different outflow diameters (10-4 mm). Furthermore, we looked material safe and satisfactory reduction effective length inflow cannula better fitting RV dimensions. Reduction graft an inner diameter ∼5 mm adds as much resistance in patients normal pulmonary...
In patients with end-stage heart failure, severe tricuspid regurgitation (TR) might be one of the signs biventricular failure subsequent need for support (biventricular assist device [BVAD]) or total artificial (TAH). However, valve repair (TVR) may avoid BVAD TAH implantation. Consecutive TR grade 3+ receiving either left ventricular concomitant TVR (group A, n = 7) a BVAD/TAH B, 18) implanted in our institution between 2007 and 2010 were compared retrospectively. Intermacs (Interagency...
Exchange of the HeartWare HVAD made necessary by thrombosis or cable damage is rare, but it a complex procedure associated with morbidity. Less invasive exchange procedures may contribute to faster postoperative recovery and early mobilization. Between September 2009 April 2012, 225 patients (median age 55.4 years, range 7-82 40 them women) were supported at our institution. Cumulative follow-up in all was 151.9 patient/years. In six patients, pump (<30 days) requiring occurred after median...